The briefing
Researchers say vaccine doses targeting the expanding Ebola outbreak centered in the Democratic Republic of the Congo could be ready for human testing within two to three months. A more promising candidate may take up to nine months to reach trials as teams race to keep pace with transmission.
Original headline
Africa races for Ebola vaccine as outbreak outpaces response